Generated: October 17, 2017
DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 203904
describes FLUDEOXYGLUCOSE F18
, which is a drug marketed by Trustees Univ Pa, Ucsf Rodiopharm, Cardinal Health 414, Methodist Hosp Res, Downstate Clincl, Wi Medcl Cyclotron, Biomedcl Res Fdn, Spectron Mrc Llc, Ucla Biomedical, Mcprf, Ncm Usa Bronx Llc, Brigham Womens, Jubilant Draximage, Cpdc, Univ Michigan, Ma General Hosp, Wusm Cyclotron, Midwest Medcl, Hot Shots Nm Llc, Kreitchman Pet Ctr, Essential Isotopes, Precision Nuclear, Univ Tx Md Anderson, Kettering Medctr, Global Isotopes Llc, Lantheus Medical, Shertech Labs Llc, Houston Cyclotron, Weill Medcl Coll, Feinstein, Queen Hamamatsu Pet, Mips Crf, 3d Imaging Drug, Mem Sloan-kettering, Childrens Hosp Mi, Petnet, Uihc Pet Imaging, Zevacor Pharma Inc, Univ North Dakota, and Univ Utah Cyclotron, and is included in forty-one NDAs. It is available from thirty-four suppliers. Additional details are available on the FLUDEOXYGLUCOSE F18 profile page.
The generic ingredient in FLUDEOXYGLUCOSE F18 is fludeoxyglucose f-18. There are eight drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the fludeoxyglucose f-18 profile page.
Summary for NDA: 203904
Pharmacology for NDA: 203904
Complete Access Available with Subscription
Summary for product number 001
|Approval Date:||Apr 23, 2015||TE:||AP||RLD:||No|
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.